Evidence map›Paper›PMID 31616289›Full record

SynthesisFrontiers in pharmacology2019

Prognostic and Clinicopathological Significance of PD-L1 in Patients With Bladder Cancer: A Meta-Analysis.

Lei Zhu, Jin Sun, Ling Wang, Zhigang Li, Lei Wang, Zhibin Li

Open access · goldAbstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 6 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 6 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Prognostic Role of CD68British journal of biomedical science · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Review
  11. Trastuzumab Deruxtecan with Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Lei ZhuDepartment of Urology, First People's Hospital of Shangqiu City, Shangqiu, China.
Jin SunDepartment of Obstetrics and Gynecology, The General Hospital of Western Theater Command, Chengdu, China.
Ling WangDepartment of Urology, Panzhihua Central Hospital, Panzhihua, China.
Zhigang LiDepartment of Urology, The General Hospital of China National Petroleum Corporation in Jilin, Jilin, China.
Lei WangDepartment of Urology, First People's Hospital of Shangqiu City, Shangqiu, China.
Zhibin LiDepartment of Urology, Shanxi Provincial Cancer Hospital, Taiyuan, China.
Panzhihua Central Hospital · CNShanxi Provincial Cancer Hospital · CNShangqiu First People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bladder cancermeta-analysisPD-L1prognosissurvival

Identifiers

PMID31616289
PMCPMC6763705
OpenAlexW2966780201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.